TrialEye (London, England)2015

High-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian population.

D M Marcus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.